A Pathology Reference Laboratory for the Study of Infectious Diseases and Malignant Lymphoma

The recruitment status of this study is unknown because the information has not been verified recently.

Verified December 2005 by National Health Research Institutes, Taiwan.
Recruitment status was Recruiting

Sponsor:

Information provided by:

National Health Research Institutes, Taiwan

ClinicalTrials.gov Identifier:

NCT00266370

First received: December 15, 2005

Last updated: December 16, 2005

Last verified: December 2005

History of Changes

Tracking Information

First Received Date ^ICMJE

December 15, 2005

Last Updated Date

December 16, 2005

Start Date ^ICMJE

January 2005

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

Complete list of historical versions of study NCT00266370 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

A Pathology Reference Laboratory for the Study of Infectious Diseases and Malignant Lymphoma

Official Title ^ICMJE

A Pathology Reference Laboratory for the Study of Infectious Diseases and Malignant Lymphoma

Brief Summary

To establish a pathology reference laboratory for the consultation on the diagnosis of infectious diseases and lymphoma.
To study the specific pathogens on 100 cases of unexplained death due to infectious diseases in the files of Taiwan CDC and the Forensic Institutes of Department of Law and Justice.
To study the distribution of children lymphoid lesions in Vietnam and Taiwan and their virus association.
To establish a tissue bank for infectious diseases and lymphoma.

Detailed Description

Not Provided

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Additional Descriptors: Psychosocial
Observational Model: Case Control
Time Perspective: Longitudinal
Time Perspective: Retrospective/Prospective

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Not Provided

Study Population

Not Provided

Condition ^ICMJE

Lymphoma

Intervention ^ICMJE

Not Provided

Study Group/Cohort (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Enrollment ^ICMJE

100

Completion Date

December 2009

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Clinical diagnosis of infectious diseases and lymphoma.

Exclusion Criteria:

Gender

Both

Ages

Not Provided

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact: Ih-Jen Su, M.D., Ph. D.

886-6-2083422

Location Countries ^ICMJE

Taiwan

Administrative Information

NCT Number ^ICMJE

NCT00266370

Other Study ID Numbers ^ICMJE

CL-094-CP-01

Has Data Monitoring Committee

Not Provided

Responsible Party

Not Provided

Study Sponsor ^ICMJE

National Health Research Institutes, Taiwan

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Principal Investigator:

Ih-Jen Su, M.D., Ph.D.

Division of Clinical Research, National Health Research Institutes

Information Provided By

National Health Research Institutes, Taiwan

Verification Date

December 2005

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top